Physician profile
Patrick Hunter Knight
NPI 1376997692
$1,378.70
in general payments reported to CMS, 2019-2025
8 companies · $839 in 2025
The $839 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $305 · 2022: $14.89 · 2023: $39.17 · 2024: $181 · 2025: $839.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,059.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,058.81 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Penumbra, INC. | $328.08 | 2025 | Indigo System |
| Medical Device Business Services, INC. | $305.00 | 2019 | |
| Medtronic, INC. | $221.77 | 2022-2025 | Endurant Iis |
| Stryker Corporation | $172.20 | 2025 | Limflow System |
| Silk Road Medical, INC. | $157.90 | 2024 | Enroute Transcarotid Neuroprotection System, Enroute Enflate Transcarotid Rx Balloon Dilatation Catheter, Enroute Transcarotid Stent |
| Shape Memory Medical INC. | $131.61 | 2025 | Impede Embolization Plug |
| Haemonetics Corporation | $39.17 | 2023 | Teg5000 Hemostasis Analyzer |
| W. L. Gore & Associates, INC. | $22.97 | 2024 | Excluder Conformable Aaa Endoprosthesis With Active Control |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Patrick Knight listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.